Unknown

Dataset Information

0

Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China.


ABSTRACT:

Introduction

Reliable country-specific incidence and cost data on diabetes-related complications are essential inputs for the projections of the economic burden of diabetes. The aim of this study was to provide patient-level cost estimates of managing and treating complications in patients newly diagnosed with type 2 diabetes mellitus (T2DM) in China.

Methods

Patients newly diagnosed with T2DM in the Tianjin Urban Employee Basic Medical Insurance Claims database between 2008 and 2015 were identified and followed up. The cumulative incidence and descriptive costs of certain macrovascular and microvascular complications were examined. A generalized estimating equations model was used to estimate the immediate- and long-term costs for the incident complication in quarterly intervals, controlling for demographics and the confounding effects of comorbid complications.

Results

A total of 114,847 newly diagnosed patients were identified (mean age 56.9 years, 45.5% women). After 7 years, 80.8% of the patients at risk had developed nephropathy and 75.7% had developed neuropathy. The immediate additional costs were highest for myocardial infarction during the quarterly interval that the complication first occurred (China yuan [CNY] 19,633), and the long-term costs were highest for stroke in the quarterly intervals of subsequent years (CNY 1087). The expected costs for all complications were calculated and presented as costs per quarterly interval and per year for different age and sex subgroups.

Conclusions

Managing complications results in substantial costs to the Chinese healthcare system. Our study contributes towards quantifying the economic burden and supports the parametrization of economic models of diabetes in China.

SUBMITTER: He X 

PROVIDER: S-EPMC7843809 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China.

He Xiaoning X   Zhang Yawen Y   Zhou Yan Y   Dong Chaohui C   Wu Jing J  

Diabetes therapy : research, treatment and education of diabetes and related disorders 20201118 1


<h4>Introduction</h4>Reliable country-specific incidence and cost data on diabetes-related complications are essential inputs for the projections of the economic burden of diabetes. The aim of this study was to provide patient-level cost estimates of managing and treating complications in patients newly diagnosed with type 2 diabetes mellitus (T2DM) in China.<h4>Methods</h4>Patients newly diagnosed with T2DM in the Tianjin Urban Employee Basic Medical Insurance Claims database between 2008 and 2  ...[more]

Similar Datasets

| S-EPMC6224711 | biostudies-literature
| S-EPMC5829109 | biostudies-literature
| S-EPMC162128 | biostudies-literature
| S-EPMC9276720 | biostudies-literature
| S-EPMC7389482 | biostudies-literature
| S-EPMC5972121 | biostudies-literature
| S-EPMC5047944 | biostudies-literature
| S-EPMC3302892 | biostudies-literature
| S-EPMC9786655 | biostudies-literature
| S-EPMC6362488 | biostudies-literature